Funapide
Funapide (INN) (former developmental code names TV-45070 and XEN402) is a novel analgesic under development by (formerly in partnership with Teva Pharmaceutical Industries) for the treatment of a variety of chronic pain conditions, including osteoarthritis, neuropathic pain, postherpetic neuralgia, and erythromelalgia, as well as dental pain. It acts as a small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker. Funapide is being evaluated in humans in both oral and topical formulations, and as of July 2014, has reached phase IIb clinical trials.
Link from a Wikipage to another Wikipage
primaryTopic
Funapide
Funapide (INN) (former developmental code names TV-45070 and XEN402) is a novel analgesic under development by (formerly in partnership with Teva Pharmaceutical Industries) for the treatment of a variety of chronic pain conditions, including osteoarthritis, neuropathic pain, postherpetic neuralgia, and erythromelalgia, as well as dental pain. It acts as a small-molecule Nav1.7 and Nav1.8 voltage-gated sodium channel blocker. Funapide is being evaluated in humans in both oral and topical formulations, and as of July 2014, has reached phase IIb clinical trials.
has abstract
Funapide (INN) (former develop ...... hed phase IIb clinical trials.
@en
CAS number
1259933-16-8
FDA UNII code
A5595LHJ2L
KEGG
PubChem
Link from a Wikipage to an external page
Wikipage page ID
43,348,294
page length (characters) of wiki page
Wikipage revision ID
1,000,086,365
Link from a Wikipage to another Wikipage
ATC prefix
None
@en
CAS number
ChemSpiderID
34,500,834
IUPAC name
KEGG
D11156
@en
PubChem
49,836,093
routes of administration
SMILES
C1C2C5=CC6=COCO6
@en
StdInChIKey
NEBUOXBYNAHKFV-NRFANRHFSA-N
@en
UNII
A5595LHJ2L
@en
wikiPageUsesTemplate
subject
hypernym
comment
Funapide (INN) (former develop ...... hed phase IIb clinical trials.
@en
label
Funapide
@en